S&P 500
1664.43
-1.86 -0.11%
Dow Indu
15341.16
+5.88 +0.04%
Nasdaq
3490.94
-5.49 -0.16%
Crude Oil
96.25
-0.68 -0.70%
Gold
1369.00
-17.48 -1.26%
Euro
1.28624
-0.00117 -0.09%
US Dollar
84.068
+0.312 +0.40%
Weak

Chicago Mercantile ExchangeMILK CLASS IV Jun 2013 (E) (CME:GDK.M13.E)

19.25 0.00 (0.00%)

2013-05-20 17:21:31, 10 min delay

MILK CLASS IV Jun 2013 (E) (CME:GDK.M13.E)
1 Day
3 Day
5 Day
1 Month
3 Month
6 Month
1 Year
Max
Last Price19.25
Open19.38
Low19.28
Time2013-05-20 17:21:31
Contract High Date2013-04-18
Contract Low Date2012-05-14
Expiration2013-07-02
Close Time17:00
Settle Time17:21
Previous Close19.25
Open Int.308
Contract High20.43
Contract Low15.05
Estimated Volume25
Open Time18:00

Today's Top 50 Trending Stocks: Let our SmartScan and Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly rank today's top 50 stocks for you. This complimentary list will update throughout the day to highlight the most timely trading opportunities.

First Name
Last Name
Email
 
By filling out the form, you'll receive instant access to Today's Top 50 Trending Stocks list and other trading resources from INO.com.

List of Top Stocks


Trader's Blog

Poll: What do you think of U.S. taxes? 18 minutes ago
Supercharge Your Portfolio With These Powerful ETFs 1 hour, 10 minutes ago
Today's Video Update: Yahoo Bets A Billion 21 hours ago
Gold Chart of The Week 1 day ago

Today's News

AP Top Financial News At 10 a.m. EDT

50 minutes ago

Apple's Cook to face Senate questions on taxes Indexes edge higher on Wall Street in early trade Best Buy reports 1Q loss on restructuring costs

TJX 1Q net income rises 8 pct, sales increase

56 minutes ago

TJX, parent company of TJ Maxx and Marshalls clothing stores, said Tuesday its fiscal first-quarter net income rose 8 percent to match Wall Street predictions. Revenue increased 7 percent to $6.19 billion from $5.8 billion. Analysts, on average, expected a profit of 62 cents per share, on $6.18 billion in revenue, according to FactSet.

France: Drugmaker on trial, suspected in deaths

56 minutes ago

A French drug company and its founder are on trial on charges of misleading the public about a diabetes drug marketed as a weight loss method and suspected in hundreds of deaths. Between 1976 and 2009, around 5 million people took Mediator, designed as a diabetes drug but widely promoted for weight loss. Mediator's creators, Servier Laboratories, face charges of "aggravated deception" in a trial that opened Tuesday in Nanterre, outside Paris.

AP Top Extended Financial Headlines At 9:47 a.m. EDT

58 minutes ago

Apple CEO Cook to testify before Senate panel after report says it avoids billions in taxes Best Buy reports 1Q loss on restructuring costs, adjusted earnings beats expectations

INO.com on Facebook INO.com MarketClub on Twitter INO.com YouTube

© Copyright INO.com, Inc. All Rights Reserved.